SCHEMBL7445903

SCHEMBL7445903

O=C(O)C(CC1CCNO1)(c1ccccc1)N1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 11/20 0.38
CYP2B6 P20813 1/20 0.35
CHRM2 P08172 4/20 0.33
CHRM1 P11229 4/20 0.33
CYP2D6 P10635 3/20 0.33
KCNH2 Q12809 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
HRH1 P35367 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7507898 0.91 MEN1 (0.37) CHRM3CHRM2CHRM1CYP2D6CHRM4
SCHEMBL7445905 0.76 CHRM3 (0.35) CHRM3CYP2B6CHRM2CHRM1CYP2D6
SCHEMBL2125965 0.72 CHRM3 (0.48) CHRM3CHRM2CHRM1CYP2D6KCNH2
SCHEMBL2126331 0.72 CHRM3 (0.48) CHRM3CHRM2CHRM1CYP2D6KCNH2
SCHEMBL2126336 0.72 CHRM3 (0.48) CHRM3CHRM2CHRM1CYP2D6KCNH2
SCHEMBL2125962 0.72 CHRM3 (0.48) CHRM3CHRM2CHRM1CYP2D6KCNH2
SCHEMBL2127685 0.72 CYP2B6 (0.50) CHRM3CYP2B6CHRM2CHRM1CYP2D6
SCHEMBL2128439 0.72 CYP2B6 (0.50) CHRM3CYP2B6CHRM2CHRM1CYP2D6
SCHEMBL327106 0.71 CYP2B6 (0.45) CHRM3CYP2B6CHRM2CHRM1CYP2D6
SCHEMBL7126061 0.70 CYP2B6 (0.45) CHRM3CYP2B6CHRM2CHRM1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1131306-A2 ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2001-09-12 EP disclosed
WO-2000029406-A2 NOVEL ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 2000-05-25 WO disclosed